CEACAM5 and neoplasm: Two potential explanations for this effect could be: (i) there is tumor heterogeneity where the subtype with CEACAM5 expression is selectively killed by the (radio)chemotherapy [51–53], or (ii) the neoadjuvant therapy has a selective effect on the cell genome [54].